LOX: Catheters, Transluminal Coronary Angioplasty, Percutaneous: FDA Product Code 510(k) Clearances, Predicate Lineage, and Recall History (1982 to 2026)

U.S. FDA CDRH three-letter product classification LOX in Cardiovascular (21 CFR 870.5100) reconciled across 1982 to 2026.

Review 88 FDA 510(k) clearances, 10 recalled K-numbers, and 121 cumulative 1976 to 2026 CDRH recall notices for LOX: Catheters, Transluminal Coronary Angioplasty, Percutaneous on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for LOX: Catheters, Transluminal Coronary Angioplasty, Percutaneous
Regulatory MetricVerified Value
Entity ClassificationFDA 3-Letter Product Code (LOX, Class 2)
Clinical Advisory SpecialtyCardiovascular (Panel CV)
Cleared FDA 510(k) Submissions (1976 to 2026)88 clearances (24 California, 27.3%)
Cleared 510(k)s Linked to a Recall Notice10 K-numbers (11.36% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)121 notices (20 Class I, 101 Class II, 0 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (121 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances0 implantable (0.0%) and 0 life-sustaining
Median FDA 510(k) Review Duration120 days (90th percentile: 267 days)

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.